These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7806697

  • 1. Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    D'Souza DC, Bennett A, Abi-Dargham A, Krystal JH.
    J Clin Psychopharmacol; 1994 Oct; 14(5):361-3. PubMed ID: 7806697
    [No Abstract] [Full Text] [Related]

  • 2. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP, Boyer WF, Tyler DL, Neborsky RJ.
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [Abstract] [Full Text] [Related]

  • 3. Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
    Lauterbach EC.
    Mov Disord; 1994 May; 9(3):343-6. PubMed ID: 8041377
    [Abstract] [Full Text] [Related]

  • 4. [Fluoxetine and extrapyramidal symptoms. Two case reports].
    Daric C, Dollfus S, Mihout B, Omnient Y, Petit M.
    Encephale; 1993 May; 19(1):61-2. PubMed ID: 8275894
    [No Abstract] [Full Text] [Related]

  • 5. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandöl E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1493-9. PubMed ID: 17688987
    [Abstract] [Full Text] [Related]

  • 6. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH, Byun HJ.
    J Clin Pharm Ther; 2007 Oct 01; 32(5):461-7. PubMed ID: 17875112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct 01; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 9. Reply to Dr. J-C Shim and colleagues regarding "Fluoxetine augmentation of haloperidol in chronic schizophrenia" [J Clin Psychopharmacol 2003;23:520-521].
    Mackin P, Young AH.
    J Clin Psychopharmacol; 2004 Dec 01; 24(6):670. PubMed ID: 15538134
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
    Viala A, Aymard N, Leyris A, Caroli F.
    Therapie; 1996 Dec 01; 51(1):19-25. PubMed ID: 8762216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
    Shim JC, Kelly DL, Kim YH, Yoon YR, Park JH, Shin JG, Conley RR.
    J Clin Psychopharmacol; 2003 Oct 01; 23(5):520-2. PubMed ID: 14520132
    [No Abstract] [Full Text] [Related]

  • 13. Clozapine, obsessive symptoms, and serotonergic mechanisms.
    Hwang MY, Stein D, Simeon D, Hollander E.
    Am J Psychiatry; 1993 Sep 01; 150(9):1435. PubMed ID: 8352368
    [No Abstract] [Full Text] [Related]

  • 14. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M, Gorwood P, Stalla-Bourdillon A, Adès J.
    Encephale; 1993 Sep 01; 19(1):17-21. PubMed ID: 8275889
    [Abstract] [Full Text] [Related]

  • 15. Addition of fluoxetine to treatment of schizophrenic patients.
    Bacher NM, Ruskin P.
    Am J Psychiatry; 1991 Feb 01; 148(2):274. PubMed ID: 1670983
    [No Abstract] [Full Text] [Related]

  • 16. Addition of fluoxetine to clozapine.
    Cassady SL, Thaker GK.
    Am J Psychiatry; 1992 Sep 01; 149(9):1274. PubMed ID: 1503143
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Priapism in neuroleptic therapy].
    Eikmeier G.
    Nervenarzt; 1987 Dec 01; 58(12):771-2. PubMed ID: 3431614
    [Abstract] [Full Text] [Related]

  • 19. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS, Paige SR, Newton JE.
    Mov Disord; 1993 Dec 01; 8(1):43-6. PubMed ID: 8093548
    [Abstract] [Full Text] [Related]

  • 20. [Antidepressant treatment of schizophrenic patients].
    Caroli F, Baldacci-Epinette C, Ribeyre P.
    Encephale; 1993 Jul 01; 19 Spec No 2():393-6. PubMed ID: 7904237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.